Abdelrahman M Attia

5PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - lipidsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2026
Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis.

Mohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari

|Sep 04, 2025
Changing landscape of steatotic liver diseases and liver fibrosis in the United States during the COVID-19 pandemic.

Abdelrahman M Attia, Mohammad Saeid Rezaee-Zavareh, Yee Hui Yeo

|May 16, 2025
Immune-Related Adverse Events Are Associated With Improved Outcomes After Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Soo Young Hwang, Mohammad Saeid Rezaee-Zavareh, Abdelrahman M Attia

|Oct 25, 2024
Novel Biomarkers for Early Detection of Hepatocellular Carcinoma.

Abdelrahman M Attia, Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang

Pageof 1